Skip to content

PipeBio

YC W21 · Acquired · PipeBio is a SaaS bioinformatics platform to develop antibody drugs.

Competitors

Adjacent

Also from W21 in AI

All of W21

About PipeBio

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

YC batch
W21 · Winter 2021
Status, per YC
Acquired
Category
AI
Team size
10
Location
Aarhus, Denmark; Remote
Checked
31m ago

YC tags: AI-powered Drug Discovery, Machine Learning, SaaS

PipeBio in W21: 336 companies, 30% AI

PipeBio: questions

Which YC batch was PipeBio in?

PipeBio was in Y Combinator's Winter 2021 batch (W21).

Is PipeBio still active?

Y Combinator lists PipeBio as acquired.

Where is PipeBio based?

PipeBio lists Aarhus, Denmark; Remote as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.